IndieBio
 IndieBio logo displaying a hybrid form between DNA and antibody. | |
| Industry | Venture capital |
|---|---|
| Founded |
Cork, Ireland (2014, as Synbioxlt8r, LLC.) |
| Headquarters | Cork, Ireland; San Francisco, California |
Key people |
Bill Liao |
| Products | Investments |
| Website | www.indiebio.co |
IndieBio is the world's first startup accelerator for synthetic biology. It holds three-month programs for startups in Cork (Ireland) and San Francisco (USA) on a yearly basis.[1] It is backed by the venture capital fund SOSV.[2]
In exchange for equity, participating teams can profit from early seed funding to build a minimal viable product in a lab environment. The 3 month lab access, the possibility to profit from the mentorship program and the access to the network of the SOSV venture capital fund are valued as an additional non cash component. IndieBio startup teams are required to move to San Francisco or Cork for the duration of the program, where they work closely the mentors and IndieBio partners to get them ready for a first investment round.[3]
Shortly after the laboratory phase of the program, the first public business model and product demonstration is conducted in front of a selected audience and published via live stream. However, potential investors are brought into the labs throughout the development phase.[4] [5]
References
- ↑ IndieBio Will Accelerate Synthetic Biology To Tech Startup Speed (Feb 20, 2015), Anthony Wing Kosner, Forbes
- ↑ SOSV Accelerator Programs (Aug 28, 2015), SOSV
- ↑ Biotech Accelerator IndieBio Bumps Funding To $250K Per Startup To Give Founders More Runway (May 12, 2015), Sarah Buhr, TechCrunch
- ↑ 9 global start-ups strut their stuff at Indie Bio Demo Day in Cork (Aug 13, 2015), Connor McKenna, Silicon Republic
- ↑ The 12 Startups That Launched At Biotech Accelerator IndieBio’s First Ever Demo Day (June 11, 2015), Sarah Buhr, TechCrunch
External links
| |||||||||||||||||||||||||||||||||||||||
